Common Contracts
5 similar Consulting Agreement contracts by Nabriva Therapeutics PLC, Dermata Therapeutics, Inc.
NABRIVA THERAPEUTICS US, INC. CONSULTING AGREEMENTConsulting Agreement • July 7th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Consulting Agreement (“Agreement”) is effective as of July 8, 2023 (the “Effective Date”) by and between Nabriva Therapeutics US, Inc., a Delaware corporation, with a business address of 414 Commerce Drive, Suite 120, Fort Washington PA 19304 (“Company”), and J. Christopher Naftzger having an address at [**] (“Consultant”).
NABRIVA THERAPEUTICS US, INC. CONSULTING AGREEMENTConsulting Agreement • July 7th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Consulting Agreement (“Agreement”) is effective as of July 1, 2023 (the “Effective Date”) by and between Nabriva Therapeutics US, Inc., a Delaware corporation, with a business address of 414 Commerce Drive, Suite 120, Fort Washington PA 19304 (“Company”), and Daniel Dolan having an address at [**] (“Consultant”).
NABRIVA THERAPEUTICS US, INC. CONSULTING AGREEMENTConsulting Agreement • January 20th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Consulting Agreement (“Agreement”) is effective as of January 16, 2023 (the “Effective Date”) by and between Nabriva Therapeutics US, Inc., a Delaware corporation, with a business address of 414 Commerce Drive, Suite 120, Fort Washington PA 19304 (“Company”), and Steven P. Gelone having an address at [**] (“Consultant”).
NABRIVA THERAPEUTICS US, INC. CONSULTING AGREEMENTConsulting Agreement • January 20th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Consulting Agreement (“Agreement”) is effective as of January 16, 2023 (the “Effective Date”) by and between Nabriva Therapeutics US, Inc., a Delaware corporation, with a business address of 414 Commerce Drive, Suite 120, Fort Washington PA 19304 (“Company”), and Theodore R. Schroeder having an address at [**] (“Consultant”).
DERMATA THERAPEUTICS, INC. CONSULTING AGREEMENTConsulting Agreement • September 1st, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • California
This Consulting Agreement (“Agreement”) is effective as of September 1, 2021 (the “Effective Date”) by and between Dermata Therapeutics, INC., a Delaware corporation having its mailing address located at 3525 Del Mar Heights Rd. #322, San Diego, CA 92130 (“Company”), and Thomas Insley (“Consultant”).
